AGC Biologics expands viral vector manufacturing capabilities in Milan

AGC has extended its Milan manufacturing facility to address the growing clinical trial and commercial demands. Author Livio Andrea Acerbo Digital nomad, tech enthusiast and information driven View all posts http://acerbo.me livio@acerbo.me Acerbo Livio Andrea

AGC has extended its Milan manufacturing facility to address the growing clinical trial and commercial demands.

Author

Leave a Comment

Your email address will not be published. Required fields are marked *